Benchmark Research Seeking Austinites for COVID Vaccine Trial

COVID 19 HOSPITALIZATIONS UT PREDICTION GETTING WORSE

This month, Benchmark Research will launch clinical research trials to test vaccines aimed at preventing the spread of COVID-19 in Austin.  The company operates a handful of sites in Texas, including in Austin, and says the city is a prime location due to the rising number of cases in recent weeks.  While anyone over the age of 18 is encouraged to consider taking part, Benchmark Research says front-line workers, people likely to be exposed to the virus, people over 65, and others at high-risk with chronic health conditions likely will get first priority.

“The global effort to develop a vaccine has resulted in the need for thousands of study participants to join this historic fight,” Mark Lacy, chief executive officer at Benchmark Research, said. “We know that Austinites and central Texans feel like the problem is bigger than themselves, and this is an ideal way to be a part of the solution.”

Over the course of the trial, participants will be paid for their participation, which will include a specified number of visits to the facility and answering periodic phone calls regarding the study, Benchmark says in a release.  Insurance is not required to take part.

“I have worked to develop therapies and treatments for 16 years, and this is one of the most important of our time,” Laurence Chu, M.D., investigator at Benchmark Research, said. “A number of diseases that were once prevalent and often deadly, such as Polio, have been all but forgotten with the development of a vaccine. I can’t overstate the importance of having willing participants to further research needed to develop a viable vaccine for COVID-19.”

Those interested should call 1-888-902-9605 or visit: www.benchmarkresearch.net to learn more.

Share this Posts

Related Posts

Loading...